Legend Biotech (LEGN) Interest Coverage Ratio (2019 - 2026)
Legend Biotech (LEGN) posted quarterly Interest Coverage Ratio of 9.05 for Q1 2026, up 10.68% year-on-year from 8.18 in Q1 2025, and down 352.79% on a QoQ basis from 3.58 in Q4 2025.
Legend Biotech (LEGN) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has reported Interest Coverage Ratio for 8 consecutive years, with 9.05 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 10.68% year-over-year to 9.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.41 (up 307.2% YoY) and the FY2025 annual result came in at 6.38, up 144.55% from the prior year.
- Interest Coverage Ratio fell to 9.05 in Q1 2026 per LEGN's latest filing, from 3.58 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for LEGN reached as high as 55.74 in Q2 2025 and fell as low as 13648055.74 in Q4 2023.
- A 5-year average of 802833.09 and a median of 10.14 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 2232.99% — and 2023, when it slumped 59178890.36%.
- Year by year, Interest Coverage Ratio stood at 23.06 in 2022, then sank by 59178890.36% to 13648055.74 in 2023, then soared by 100.0% to 15.25 in 2024, then tumbled by 76.51% to 3.58 in 2025, then tumbled by 352.79% to 9.05 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 9.05, 3.58, and 7.71 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Legend Biotech | 8.69 Bn | 7.79 Bn | 129.70 Mn | -9.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.05 |
| Dec 31, 2025 | 3.58 |
| Sep 30, 2025 | -7.71 |
| Jun 30, 2025 | 55.74 |
| Mar 31, 2025 | -10.14 |
| Dec 31, 2024 | 15.25 |
| Sep 30, 2024 | 12.78 |
| Jun 30, 2024 | -52.73 |
| Mar 31, 2024 | -32.47 |
| Dec 31, 2023 | -13.65 Mn |
| Sep 30, 2023 | 6.72 |
| Jun 30, 2023 | -10.65 |
| Mar 31, 2023 | -21.09 |
| Dec 31, 2022 | -23.06 |
| Sep 30, 2022 | -15.04 |
| Jun 30, 2022 | -50.75 |
| Mar 31, 2022 | 31.77 |
| Dec 31, 2021 | 147.73 |
| Sep 30, 2021 | 600.76 |
| Jun 30, 2021 | -1,913.61 |